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Abstract: Problem statement: Mammalian cells were used for the production of oligosaccharides by 
saccharide primer method. However, because cells in culture are used, productivity of oligosaccharides 
is low. Approach: In saccharide primer  method employing cells under culture, glycosylation  was 
performed only by mixing the collected cells in reaction mixtures. Saccharide primer, 12-azidododecyl 
￿-lactoside that mimics lactosylceramide (LacCer), was incubated with various mammalian cells under 
stirring or static conditions. The glycosylated primers were generated by adding and agitating cells in 
reaction mixtures like in the case where cells in culture were treated with saccharide primer. Results: 
In  the  case  of  African  green-monkey  kidney  (Vero)  cells,  the  amount  of  generated  GM3-type 
oligosaccharide  increased  approximately  five  times  by  the  reaction  under  agitating  condition  as 
compared with the reaction with cells in culture. GM3-type oligosaccharide was also synthesized by 
mouse  melanoma B16 cells under both agitating or standing conditions. Moreover, the amount of 
GM3-type and GM1-type oligosaccharides produced by using African green-monkey kidney COS7 
cells  only  by  mixing  the  collected  cells  was  greater  than  the  general  saccharide  primer  method. 
Conclusions/Recommendations: We demonstrated that the suspension mixture of the adhesive cells 
can be used as a catalyst for the synthesis of oligosaccharides in saccharide primer method. Moreover, 
suspended cells could produce more amount of oligosaccharides than normally cultured cells. 
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INTRODUCTION 
 
  Oligosaccharides (sugar chains) are recognized as 
the  third  important  molecular  chain  in  biological 
systems. Auto-sequencers and synthesizing equipment 
for  nucleic  acids  and  proteins  have  been  developed 
rapidly  hence,  researches  of  DNA  and  proteins  have 
proceeded  actively.  However,  such  equipment  is  not 
available  for  the  analysis  or  synthesis  of 
oligosaccharides.  Recently,  researches  revealed  that 
aberrations  of  oligosaccharides  are  involved  with 
pathogenesis  of  many  diseases,  such  as  cancer, 
diabetes,  hepatitis,  emphysema,  bacterial  and  virus 
infection, cranial and muscular neurological diseases
[1-
5]. Moreover, the valuable contribution of glycobiology 
in the field of medicine such as sugar chain medicine, 
sugar chain vaccine, and so on which is preceeded by 
treatment of influenza is rapidly growing
[6-8]. 
  Since  the  structures  of  oligosaccharides  are 
complicated  and  the  oligosaccharide  as  a  molecule 
cannot be amplified, studies to establish the structure 
and function of oligosaccharides lag behind. In order to 
study the role of complex sugar chains on the surface of 
cells, different oligosaccharide synthetic methods have 
been  developed.  Extraction  from  natural  organic 
resources
[9-10],  chemical  synthetic  method
[11-13]  and  a 
series of enzymatic reactions
[14-17] are among the well 
known  methods  of  preparing  oligosaccharides. 
Recently,  glycoengineered  Pichia  pastoris  strains 
capable  of  producing  humanized  glycoproteins  have 
been developed
[18-20]. In the early 1990’s, the saccharide 
primer method was developed as a novel strategy for 
the  synthesis  of  oligosaccharides.  By  this  method, 
oligosaccharides  are  synthesized  artificially  utilizing 
the  cell’s  own  oligosaccharide  synthetic  ability. 
Saccharide primers, which are used as precursors of the Am. J. Biochem. & Biotech., 4 (4): 385-392,2008 
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biosynthetic  carbohydrate  in  cells,  are  put  into  a 
medium while culturing cells
[21-23]. 12-azidododecyl ￿-
lactoside  was  glycosylated  into  GM3-type 
oligosaccharide in mouse melanoma B16 cells
[24]. Aside 
from  GM3-type  oligosaccharide,  the  12-azidododecyl 
￿-lactoside  primer  gave  Gb3-type  and  Gb4-type 
oligosaccharides in African green-monkey kidney Vero 
cells
[25], while dodecyl ￿-lactoside primer gave GM2-
type,  GM1-type  and  GD1a-type  oligosaccharides  in 
African  green-monkey  kidney  COS7
[26].  The 
oligosaccharides,  which  are  glycosylated  products  in 
the  cells,  are  secreted  out  of  cells  into  the  medium. 
Since  oligosaccharide  products  are  in  a  medium, 
purification of products is therefore easy and free from 
contamination by other cell components. Recently, an 
efficient  purification  method  by  using  Centrifugal 
Partition      Chromatography      (CPC)    has    been 
reported
[27-28]. 
  In  this  study,  we  attempted  to  synthesize 
oligosaccharides  more  efficiently  than  the  usual 
conditions  based  on  the  principle  of  the  saccharide 
primer method. We examined the efficient production 
of  oligosaccharides  only  by  mixing  cells  in  reaction 
mixtures  or  by  agitating  without  the  use  of  cells  in 
culture. 
 
MATERIALS AND METHODS 
 
  Mouse  melanoma  B16  cells,  African  green-
monkey kidney Vero cells and African green-monkey 
kidney COS7 cells were obtained from Riken Cell Bank 
(Tsukuba,  Japan).  High  performance  thin-layer 
chromatography  (HPTLC)  plates  were  from  Merck 
(Darmstadt, Germany). D-MEM and Ham’s F12 (1:1) 
(DMEM/F12)  and  antibioyic-antimycotic  (100×), 
insulin-transferrin-selenium-x  supplement  (100×), 
trypsin/EDTA  (10×)  were  purchased  from  Invitrogen 
(Tokyo,  Japan).  Fetal  Bovine  Serum  (FBS)  was 
purchased  from  Nichirei  Bioscience  (Tokyo,  Japan). 
Sep-Pak C18 was from Waters (Milford, MA, USA). 
All organic solvents used for extraction of lipids were 
purchased from Nacalai Tesque (Kyoto, Japan). 
 
Preparation of saccharide primer: Saccharide primer, 
12-azidododecyl ￿-lactoside, was prepared as described 
previously
[29].  A  dichloroethane  soln.  of  12-azido-1-
dodecanol (1.34 g, 5.89 mmol), lactose octaacetate (2.0 
g, 2.87 mmol) and 4-￿ molecular sieves were stirred at 
50°C for 1.5 h. Then, BF3·Et2O (0.5 mL) was added and 
the soln. was stirred at 50°C. After 3 h, the mixture was 
diluted with chloroform and the chloroform soln. was 
neutralized with aq. NaHCO3, washed with H2O, dried 
with anhydrous Na2SO4 and concentrated. Purification 
was performed by column chromatography (silica gel 
60,  70-230  mesh,  Merck,  Darmstadt,  Germany; 
hexane/AcOEt 2:1, v/v). 
 
Cell  culture:  Mouse  melanoma  B16  cells,  African 
green-monkey  kidney  Vero  cells  and  African  green-
monkey  kidney  COS7  cells  were  cultured  in 
DMEM/F12  supplemented  with  10%  FBS  and  1% 
antibiotic-antimycotic and detached through application 
of 0.25% trypsin/EDTA, passaged every 3-4 days and 
maintained  in  humidified  atmosphere  of  5%  CO2  at 
37°C. 
 
Oligosaccharide synthesis by cells in culture (usual 
method):  2×10
6 mouse  melanoma B16 cells, African 
green-monkey  kidney  Vero  cells  or  African  green-
monkey kidney COS7 cells were seeded into 100-mm 
culture dishes containing 7 ml of medium and incubated 
for 48 h. Then, the cells were washed with TI-DF (D-
MEM/F12  containing  1%  Insulin-Transferrin-
Selenium-X  Supplement  containing  1%  antibiotic-
antimycotic) and cells were incubated with 50 ￿M of 
12-azidododecyl ￿-lactoside (the primer was dissolve in 
DMSO to an initial concentration of 50 mM) at 37°C 
for 48 h. Prior to the incubation of cells with primer, it 
was  essential  to  remove  the  FBS  from  the  growth 
medium  by  washing  with  TI-DF,  since  serum  has 
previously been observed to interfere with ganglioside 
accumulation by the cells
[30]. 
 
Oligosaccharide  synthesis  by  cells  (modified 
method):  2×10
6  (×1),  1×10
7  (×5),  4×10
7  (×20)  and 
1×10
8  (×50)  mouse  melanoma  B16  cells,  African 
green-monkey  kidney  Vero  cells  or  African  green-
monkey kidney COS7 cells were added into 7 mL of 
reaction  solution  containing  D-MEM/F12  with  1% 
Insulin-Transferrin-Selenium-X  Supplement,  1% 
antibiotic-antimycotic  and  50  ￿M  of  12-azidododecyl 
￿-lactoside  (the  primer  was  dissolve  in  DMSO  to  an 
initial  concentration  of  50  mM).  Under  stirring 
condition,  the   reaction   solutions   were  poured  into 
20 mL vials, the spouts of vials were sealed with Air 
pore tape sheets (QIAGEN, Hilden, Germany) and then, 
they were stirred at the rate of 75 rpm in humidified 
atmosphere of 5% CO2 at 37°C for 48 h. On the other 
hand,  under  static  conditions,  the  reaction  solutions 
were poured into 100 mm culture dishes and incubated 
in humidified atmosphere of 5% CO2 at 37°C for 48 h.  
 
Extraction of oligosaccharides from medium: After 
incubation,  culture  media  or  reaction  solution  were 
collected and cells were removed by centrifugation and 
washed with PBS (-). Oligosaccharides in the culture Am. J. Biochem. & Biotech., 4 (4): 385-392,2008 
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media and PBS (-) were collected and purified using a 
Sep-Pak C18 column. After elution from the column, 
the solution was evaporated and dissolved in 50 ￿l of 
chloroform/methanol (1:2, v/v) for analysis by HPTLC. 
 
Purification of acidic glycolipids by anion exchanger 
cartridges:  Acidic  glycolipids  were  separated  from 
total  oligosaccharides  extracted  from  culture  medium 
by  InertSep  SAX,  strong  anion  exchanger  cartridges 
(GL  science,  Tokyo,  Japan),  as  described  in 
literature
[31]. InertSep SAX (500 mg) were placed in the 
extraction  manifold  apparatus  (Waters,  Milford,  MA, 
USA) and washed under vacuum (under 10 kPa) with 
10 ml of methanol and 10 ml of distilled water. The 
anion exchange resin was conditioned by washing with 
10 ml of 0.8 M ammonium acetate solution to convert 
to  acetate  ion  form  and  then  washed  with  10  ml  of 
distilled  water.  After  equilibration  with  10  ml  of 
chloroform/methanol/H2O  (5:10:1,  v/v),  the  total 
oligosaccharides extracted  from culture  medium  were 
diluted  with  chloroform/methanol/H2O  (5:10:1,  v/v) 
and  applied  to  the  cartridge  column  under  vacuum. 
Then 10 ml of chloroform/methanol/H2O (5:10:1, v/v) 
was  pulled  through  for  washing.  After  setting  a 
collection  rack  with  receiving  tubes  in  the  extraction 
manifold  apparatus,  the  cartridge  column  was  eluted 
with 10 ml of chloroform/methanol/4.0 M ammonium 
acetate  (5:10:1,  v/v).  Eluates  were  evaporated  by 
centrifugal concentrator. 
 
HPTLC analysis: Lipids from the cell homogenate and 
culture medium fraction were analyzed by HPTLC with 
chloroform/methanol/0.25 % aqueous KCl (5:4:1, v/v) 
as developing solvent. The HPTLC plates were sprayed 
with resorcinol reagent and heated at 120°C to detected 
the separated glycolipids
[24]. Densitogram was obtained 
from HPTLC results using Scion Image Software (scion 
corporation,  http://www.scioncorp.com)  to  quantify 
glycolipids. 
 
RESULTS 
 
  Mouse  melanoma  B16  cells
[24],  African  green-
monkey  kidney  Vero  cells
[25]  and  African  green-
monkey  kidney  COS7  cells
[26,32]  have  been  used  for 
oligosaccharide  production  by  saccharide  primer 
method.  In  this  regard,  mouse  melanoma  B16  cells 
sialylated  12-azidododecyl  ￿-lactoside  into  GM3-type 
oligosaccharide    by    the    action  of  cellular  enzymes 
(Fig.  1a).  In  the  same  way,  African  green-monkey 
kidney  Vero  cells  produced  Gb3-type,  Gb4-type  and 
GM3-type  oligosaccharides  (Fig.  1b),  while  African 
green-monkey  kidney  COS7  produced  GM3-type, 
GM2-type, GM1-type and GD1a-type oligosaccharides 
(Fig. 1c).  
  We attempted to synthesize oligosaccharides more 
efficiently  than  the  usual  conditions  based  on  the 
principle  of  the  saccharide  primer  method.  Initially, 
mouse melanoma B16 cells and African green-monkey 
kidney  Vero  cells  were  used  to  prepare 
oligosaccharides  by  saccharide  primer  method  under 
two different conditions. In one condition, cells  were 
suspended  with  reaction  solution  and  incubated  in 
100 mm culture dishes under static conditions. In the 
other condition, the reaction solutions with suspended 
cells were stirred at the rate of 75 rpm in 20 mL vial. In 
both conditions, the reaction solutions were incubated 
in humidified atmosphere of 5% CO2 at 37°C for 48 h. 
The  glycosylated  products  in  the  reaction  solution  of 
mouse  melanoma  B16  cells  were  extracted  and 
analyzed  by  HPTLC.  The  amount  of  GM3-type 
oligosaccharide  product  increased  with  increasing 
number  of  cells  for  both  conditions.  Under  usual 
condition using cells in culture, the amount of GM3-
type  oligosaccharides  produced  by  using  mouse 
melanoma B16 cells and African green-monkey kidney 
Vero cells were 22.6 and 8.4 nmol/dish, respectively. 
As shown in Fig. 2a and 3a, when mouse melanoma 
B16 cells were used, the static reaction condition was 
better  than  the  stirred  reaction  condition,  but  the 
amount of product in either condition did not surpass 
the amount produced under usual condition using cells 
in culture. On the other hand, the amount of GM3-type 
oligosaccharide  produced  by  using  African  green-
monkey kidney Vero cells markedly increased in both 
conditions in comparison with usual condition (Fig. 2b, 
3b).  Interestingly,  when  the  African  green-monkey 
kidney  Vero  cells  were  used,  the  stirred  reaction 
condition was suitable for the production of GM3-type 
oligosaccharide  differently  from  when  the  mouse 
melanoma  B16  cells  were  used.  It  was  possible  to 
increase  the  amount  of  production  of  GM3-type 
oligosaccharide five times at a maximum (Fig. 2b, 3b). 
It  may  be  inferred  that  the  property  of  the  cells  (for 
example, viability in floating condition or the control of 
oligosaccharides  synthesis)  is  associated  with 
conditions  suitable  for  oligosaccharides  synthesis.  As 
shown in Fig. 3b, the amounts of Gb3-type and Gb4-
type oligosaccharide produced by reaction with various 
numbers of cells were nearly constant and the ratio of 
the produced oligosaccharides changed according to the 
reaction condition. Am. J. Biochem. & Biotech., 4 (4): 385-392,2008 
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GM3-type oligosaccharide 
GM3-type oligosaccharide 
GM3-type oligosaccharide 
Gb4-type oligosaccharide 
GM3-type oligosaccharide 
GM2-type oligosaccharide 
GM1-type oligosaccharide 
GD1a-type oligosaccharide 
Saccharide primer (12-azidododecyl b- lactoside) 
 
 
Fig. 1:  Synthesis of oligosaccharides by saccharide primer  method using (a): Mouse  melanoma B16 cells, (b): 
African green-monkey kidney vero cells and (c): African green-monkey kidney COS7 cells 
 
 
1     2   3   4   5     6   7  8   9              1      2   3  4   5     6   7   8   9    10 
Gb3 type 
Gb4 type 
Gb3 type 
 
  (a)  (b) 
 
Fig. 2: Oligosaccharide production in (a): Mouse melanoma B16 cells and (b): African green-monkey kidney (Vero) 
cells. 1: Control (usual method); 2-5: Static reaction condition; 6-9: Stirred reaction condition; 10: Standard 
endogenous GM3 (2 µg). 2,6: 2×10
6 cells; 3,7: 1×10
7 cells; 4,8: 4×10
7 cells; 5,9: 1×10
8 cells Am. J. Biochem. & Biotech., 4 (4): 385-392,2008 
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Fig. 3: Amount of oligosaccharides produced in (a) mouse melanoma B16 cells and (b) African green-monkey 
kidney (Vero) cells. 1: Control (usual method); 2-5: Static reaction condition; 6-9: Stirred reaction condition; 
10: standard GM3 (2 µg). 2,6: 2×10
6 cells; 3,7: 1×10
7 cells; 4,8: 4×10
7 cells; 5,9: 1×10
8 cells 
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Fig. 4: HPTLC analysis of oligosaccharides produced in African green-monkey kidney COS7 cells after purification 
by using (a): Sep-Pak C18 and (b): Sep-Pak C18 followed by InertSep SAX. 1: Control (usual method); 2-5: 
Static reaction condition; 6-9: Stirred reaction condition; 10: Standard endogenous GM3 (1 µg) 
 
  When  African  green-monkey  kidney  COS7  cells 
were used for oligosaccharide production by saccharide 
primer method, GM3-type, GM2-type, GM1-type and 
GD1a-type oligosaccharides were obtained as described 
in  the  literature
[26,32].  However,  the  yield  of  these 
products were too low to quantify by HPTLC precisely 
(Fig.  4a).  Thereupon,  acidic  oligosaccharides  were 
separated from the total oligosaccharides, which were 
extracted from reaction solutions, by InertSep SAX. As 
shown in Fig. 4b, the bands of acidic oligosaccharides 
could be detected clearly by using anion exchange resin 
cartridge. For both static and usual reaction conditions, 
the  amounts  of  GM3-type  and  GM1-type 
oligosaccharides  increased  approximately  1.5-3  times 
when 1×10
8 African green-monkey kidney COS7 cells 
were used, but the amounts of GM2-type and GD1a-
type oligosaccharides decreased. When 1×10
8 African 
green-monkey  kidney  COS7  cells  were  used  for 
reaction under static condition, the amounts of GM3-
type  and  GM1-type  oligosaccharides  produced  were 
maximum and increased 1.8 and 7.2 times, respectively, 
compared  with  the  amount  of  oligosaccharides 
produced  under  usual  condition  using  the  cells  in 
culture (Fig. 4b). 
 
DISCUSSION 
 
  Saccharide primer method is more convenient than 
chemical  synthesis  and  is  useful  for  oligosaccharides 
synthesis. The cells are cultured in serum-free medium 
supplemented with the saccharide primer for 1-2 days. 
However,  there  is  still  a  serious  problem  i.e., 
productivity is for application to industrial production. 
We wondered if the harvested cells could be used for 
glycosylation  of  the  saccharide  primer  as  biocatalyst 
instead of using cells in culture. In this method, various Am. J. Biochem. & Biotech., 4 (4): 385-392,2008 
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cells which were obtained by cultivation or tissue cell 
dispersion may be used for oligosaccharide production 
directly  without  any  further  process  step  for 
oligosaccharide production. 
  In the case of African green-monkey kidney (Vero) 
cells,  the  amount  of  generated  GM3-type 
oligosaccharide increased approximately five times by 
the reaction under agitating condition as compared with 
the  reaction  with  cells  in  culture.  GM3-type 
oligosaccharide  was  also  synthesized  by  mouse 
melanoma B16 cells under both agitating or standing 
conditions.  Moreover,  the  amount  of  GM3-type  and 
GM1-type oligosaccharides produced by using African 
green-monkey kidney COS7 cells only by mixing the 
collected cells was greater than the general saccharide 
primer  method.  Interestingly,  in  the  case  of  African 
green-monkey  kidney  (Vero)  cells,  the  amount  of 
generated  GM3-type  oligosaccharide  increased 
approximately five times, but the amounts of generated 
Gb3 and Gb4 type oligosaccharides nearly constant as 
shown  in  Fig.  3b.  These  results  suggested  that  the 
reaction  condition  influenced  the  composition  of 
oligosaccharides  produced  from  saccharide  primers. 
When  African  green-monkey  kidney  Vero  cells  were 
used  for  oligosaccharide  production  by  saccharide 
primer  method,  each  kind of glycosyltransferase in 
the  cell  might  act  differently  under  certain  reaction 
conditions.    It  is  generally    accepted    that    the 
saccharide primer is glycosylated by the same enzyme 
as  in   the  synthesis  of  natural  glycosphingolipids
[32]. 
In  the  suspended  condition  the  saccharide  primers 
added in the reaction solution tended to be glycosylated 
by CMP-sialic acid:LacCer ￿2-3 sialyltransferase in the 
African  green-monkey  kidney  Vero  cells  more  easily 
than UDP-Gal:LacCer ￿1-4 galactosyltransferase. 
 
CONCLUSION 
 
  In this study, we demonstrated that the suspension 
mixture of the adhesive cells can be used as a catalyst 
for  the  synthesis  of  oligosaccharides  in  saccharide 
primer  method.  Moreover,  this  study  reports  that  the 
cell  strain  and  the  reaction  condition  influence  the 
amounts of oligosaccharides produced. Suspended cells 
produced  more  amount  of  oligosaccharides  than 
normally  cultured  cells.  Significantly,  the  culture 
process  can  be  skipped  and  the  amount  of  medium 
required is minimized by suspending cells in reaction 
mixture. 
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